Syneron Medical (Syneron Medical) Forward PE Ratio : 0.00 (As of Apr. 26, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Syneron Medical Forward PE Ratio?

Syneron Medical's Forward PE Ratio for today is 0.00.

Syneron Medical's PE Ratio without NRI for today is 0.00.

Syneron Medical's PE Ratio for today is 0.00.

Syneron Medical Forward PE Ratio Historical Data

The historical data trend for Syneron Medical's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneron Medical Forward PE Ratio Chart

Syneron Medical Annual Data

Trend

2015-12

2016-10

Forward PE Ratio

24.88

17.79

Syneron Medical Quarterly Data
	2015-12	2016-03
Forward PE Ratio	24.88	16.64

Competitive Comparison of Syneron Medical's Forward PE Ratio

For the Medical Devices subindustry, Syneron Medical's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syneron Medical's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Syneron Medical's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Syneron Medical's Forward PE Ratio falls into.

Syneron Medical Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Syneron Medical (NAS:ELOS) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Syneron Medical Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Syneron Medical's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Syneron Medical (Syneron Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Syneron Medical Ltd (NAS:ELOS) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.syneron.com

Syneron Medical Ltd., was incorporated in the State of Israel in July 2000. The Company completed its initial public offering of ordinary shares in August 2004. It designs, develops and markets aesthetic medical products based on its various technologies including its proprietary Electro-Optical Synergy, or ELOS, technology, which uses the synergy between electrical energy, including radiofrequency or RF energy, and optical energy to provide effective, safe and affordable aesthetic medical treatments. The Company's products, which it sells mainly to physicians and other practitioners, target non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin and laser-assisted lipolysis and topical skin brightening products.

Executives

North Tide Capital, Llc	10 percent owner	500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
Laughlin Conan	director, 10 percent owner	C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
North Tide Capital Master, Lp	10 percent owner	C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116

Syneron Medical (Syneron Medical) Headlines

From GuruFocus

Top Seth Klarman Holding, ELOS Rockets Up 20%

By matsandalex matsandalex • 02-17-2011

Why Is Seth Klarman Loading Up on Syneron Medical?

By matsandalex matsandalex • 08-29-2011

Seth Klarman More Than Doubles Holdings in Syneron Medical

By teddycx teddycx • 07-12-2011

Seth Klarman Buys First American Corp., Universal Compression Holdings, School Specialty Inc., Sells Courtside Acquisition Corp, Healthsouth Corp.

By gurufocus • 08-13-2007